Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9DZJ

Human GC-A bound to ANP and 2xREGN5308

Summary for 9DZJ
Entry DOI10.2210/pdb9dzj/pdb
Related9DZF 9DZG 9DZH
EMDB information47331
DescriptorREGN5308 - Heavy chain, REGN5308 - Light chain, Atrial natriuretic peptide receptor 1, ... (9 entities in total)
Functional Keywordsreceptor, membrane protein
Biological sourceMus musculus
More
Total number of polymer chains7
Total formula weight333786.09
Authors
Liu, S.,Huang, X.-Y. (deposition date: 2024-10-16, release date: 2026-01-21, Last modification date: 2026-08-05)
Primary citationLiu, S.,Manzo, O.,Wang, J.,Zhu, L.,Xiao, F.,Su, Y.C.,Kurre, D.,Liu, W.,Miao, Y.,Di Lorenzo, A.,Huang, X.Y.
Structural insights into single-pass transmembrane receptor GC-A activation by distinct antihypertensive antibodies.
Nat Commun, 17:-, 2026
Cited by
PubMed Abstract: The single-pass transmembrane receptor guanylyl cyclase A (GC-A), also known as natriuretic peptide receptor A (NPR-A) or NPR1, regulates blood pressure through vasodilation and natriuresis, making it a promising therapeutic target for hypertension and heart failure. We describe two monoclonal antibodies, XX16 and REGN5308, that differentially activate GC-A. Using cryo-electron microscopy and molecular dynamics simulations, we reveal that XX16 stabilizes GC-A in an active conformation even without its ligand ANP, whereas REGN5308 requires ANP to fully promote receptor activation. Both antibodies increase ANP binding affinity to GC-A and enhance GC-A-mediated cGMP signaling, although XX16 exerts a stronger stabilizing influence on ATP and GTP binding. In a mouse model of obesity-induced hypertension, XX16 treatment significantly reduces blood pressure, underscoring its therapeutic potential. These findings outline the structural and functional basis of GC-A activation by antibody positive allosteric modulators, offering strategies for durable antihypertensive therapies and improved management of cardiovascular diseases.
PubMed: 41942428
DOI: 10.1038/s41467-026-71594-7
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.7 Å)
Structure validation

257629

PDB entries from 2026-08-05

PDB statisticsPDBj update infoContact PDBjnumon